Literature DB >> 10632348

Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.

P Visca1, P L Alò, F Del Nonno, C Botti, G Trombetta, F Marandino, S Filippi, U Di Tondo, R P Donnorso.   

Abstract

The normal mucosa-adenoma-carcinoma sequence in colon pathology provides an attractive model of tumor progression. The role of tumor suppressor genes, oncogenes, and proliferative markers in tumorogenesis has evolved considerably in the last decade. By immunohistochemistry means, we have studied p53, bcl-2, c-myc, p21-ras, ki67, and fatty acid synthase (a fatty-acid-synthesizing enzyme) in normal, dysplastic, and neoplastic mucosa. The results were correlated with clinicopathological features and overall survival (OS). Formalin-fixed, paraffin-embedded archival material from 100 nonconsecutive adenomas and 100 adenocarcinomas (ADCs), including adjacent-to-tumor nonneoplastic mucosa (ANNM), from patients with a 5-year follow-up period were studied. Negative controls were obtained from colon resections for nonneoplastic disease. Fatty acid synthase was associated with ADC (P = 0.0001). p53 protein was associated with high-grade dysplasia adenoma (AHGD), ADC (P = 0.0001), and pT stage (P = 0.003). bcl-2 was associated with adenomas with low-grade dysplasia (P = 0.009); c-myc was associated with ANNM (P = 0.005) and pT stage (P = 0.006). p21-ras was associated with AHGD (P = 0.0001) and ANNM (P = 0.01). Ki67 was associated with AHGD (P = 0.02) and ADC (P = 0.0001). Univariate analysis on neoplastic tissue revealed histological grade, pT stage, pN stage, p21-ras, and p53 to be significant markers of OS; p21-ras, p53, and c-myc were reliable markers when evaluated on ANNM. Multivariate analysis revealed pT stage, pN stage, and p21-ras to be independent prognosticators of OS on ADC; p21-ras and c-myc staining in the ANNM were correlated with worse survival (OS). We suggest that the evaluation in concert of clinicopathological data and immunohistochemical markers on both normal and abnormal colon tissue provides an attractive model of tumor progression; moreover, it may give important messages about the prediction of survival.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10632348

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  17 in total

1.  Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study.

Authors:  Aya Kuchiba; Teppei Morikawa; Mai Yamauchi; Yu Imamura; Xiaoyun Liao; Andrew T Chan; Jeffrey A Meyerhardt; Edward Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

2.  Altered Saturated and Monounsaturated Plasma Phospholipid Fatty Acid Profiles in Adult Males with Colon Adenomas.

Authors:  C Austin Pickens; Ami Lane-Elliot; Sarah S Comstock; Jenifer I Fenton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-31       Impact factor: 4.254

3.  Fatty Acid Synthase and Acetyl-CoA Carboxylase Are Expressed in Nodal Metastatic Melanoma But Not in Benign Intracapsular Nodal Nevi.

Authors:  Jad Saab; Maria Laureana Santos-Zabala; Massimo Loda; Edward C Stack; Travis J Hollmann
Journal:  Am J Dermatopathol       Date:  2018-04       Impact factor: 1.533

4.  Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker.

Authors:  Hailan Liu; Jing-Yuan Liu; Xi Wu; Jian-Ting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2010-07-18

5.  Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells.

Authors:  Maria Notarnicola; Simona Pisanti; Valeria Tutino; Domenica Bocale; Maria Teresa Rotelli; Antonio Gentile; Vincenzo Memeo; Maurizio Bifulco; Enzo Perri; Maria Gabriella Caruso
Journal:  Genes Nutr       Date:  2010-05-16       Impact factor: 5.523

6.  Interleukin-6 affects cell death escaping mechanisms acting on Bax-Ku70-Clusterin interactions in human colon cancer progression.

Authors:  Sabina Pucci; Paola Mazzarelli; Mazzarelli Paola; Fabiola Sesti; Sesti Fabiola; David A Boothman; Boothman A David; Luigi G Spagnoli; Spagnoli G Luigi
Journal:  Cell Cycle       Date:  2009-02-18       Impact factor: 4.534

7.  Cohort study of fatty acid synthase expression and patient survival in colon cancer.

Authors:  Shuji Ogino; Katsuhiko Nosho; Jeffrey A Meyerhardt; Gregory J Kirkner; Andrew T Chan; Takako Kawasaki; Edward L Giovannucci; Massimo Loda; Charles S Fuchs
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

8.  Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention.

Authors:  Kathleen E Kearney; Thomas G Pretlow; Theresa P Pretlow
Journal:  Int J Cancer       Date:  2009-07-01       Impact factor: 7.396

9.  Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes.

Authors:  Sabrina D Silva; Isabela W Cunha; Ana Lúcia C A Rangel; Jacks Jorge; Karina G Zecchin; Michelle Agostini; Luiz P Kowalski; Ricardo D Coletta; Edgard Graner
Journal:  Virchows Arch       Date:  2008-06-06       Impact factor: 4.064

10.  CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.

Authors:  Ron Firestein; Kaori Shima; Katsuhiko Nosho; Natsumi Irahara; Yoshifumi Baba; Emeric Bojarski; Edward L Giovannucci; William C Hahn; Charles S Fuchs; Shuji Ogino
Journal:  Int J Cancer       Date:  2010-06-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.